Srishti Khurana

To Advance the Developments in RNAi Therapeutics, the Developers are actively Seeking for Fundraiser Opportunities

Over the years, monetary assistance from angel investors, venture capitalists, and funding schemes of various public and private organizations / funds, along with assistance from regulatory authorities, have allowed start-ups / small companies to further their R&D efforts related to the development of RNAi therapeutics.